Company: ERAS
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103868
Chunk: 54

Company: Erasca, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 54
---
 15, 2025 or that will become exercisable within 60 days after such date. |

| (14) | Includes 494,999 shares of common stock underlying options held by Dr. Varney that are exercisable as of April 15, 2025 or that will become exercisable within 60 days after such date. |

| (15) | Consists of shares of common stock and shares of common stock issuable upon exercise of outstanding options which are exercisable as of April 15, 2025 or that will become exercisable within 60 days after such date, as set forth in previous footnotes. Also includes 21,174 shares of common stock held by Ebun S. Garner, J.D., our General Counsel and Corporate Secretary, and 1,290,941 shares of common stock underlying options held by Mr. Garner that are exercisable as of April 15, 2025 or that will become exercisable within 60 days after such date. |

**37

Certain Relationships and Related Person Transactions

The following is a summary of transactions entered into or existing since January 1, 2023 to which we have been a party in which the amount involved exceeded or will exceed $120,000 (or, if less, 1% of the average of our total assets at year-end for the last two completed fiscal years), and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other arrangements, which are described under “Executive and Director Compensation.” We also describe below certain other transactions with our directors, executive officers and stockholders.

Stockholders’ agreement

We entered into an amended and restated stockholders’ agreement in April 2020, or the stockholders’ agreement, with the holders of our convertible preferred stock, including entities with which certain of our directors are affiliated. This agreement provides for certain rights relating to the registration of their shares of common stock issuable upon conversion of their convertible preferred stock and certain additional covenants made by us. Except for the registration rights (including the related provisions pursuant to which we have agreed to indemnify the parties to the stockholders’ agreement), all rights under this agreement terminated upon closing of our IPO. The registration rights will terminate five years after the closing of our